Corbenic Partners LLC Mesoblast LTD Transaction History

Corbenic Partners LLC

  • $380 Million
  • Q2 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 29, 2021
SELL
$8.21 - $18.59 $24,630 - $55,770
-3,000 Closed
0 $0
Q3 2020

Oct 09, 2020
BUY
$11.33 - $19.81 $33,990 - $59,429
3,000 New
3,000 $56,000

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.14B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Corbenic Partners LLC Portfolio

Follow Corbenic Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corbenic Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corbenic Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email